146 related articles for article (PubMed ID: 32286937)
1. Rational Design and Intramolecular Cyclization of Hotspot Peptide Segments at YAP-TEAD4 Complex Interface.
Zhang D; He D; Pan X; Liu L
Protein Pept Lett; 2020; 27(10):999-1006. PubMed ID: 32286937
[TBL] [Abstract][Full Text] [Related]
2. Effect of the acylation of TEAD4 on its interaction with co-activators YAP and TAZ.
Mesrouze Y; Meyerhofer M; Bokhovchuk F; Fontana P; Zimmermann C; Martin T; Delaunay C; Izaac A; Kallen J; Schmelzle T; Erdmann D; Chène P
Protein Sci; 2017 Dec; 26(12):2399-2409. PubMed ID: 28960584
[TBL] [Abstract][Full Text] [Related]
3. Structural basis of YAP recognition by TEAD4 in the hippo pathway.
Chen L; Chan SW; Zhang X; Walsh M; Lim CJ; Hong W; Song H
Genes Dev; 2010 Feb; 24(3):290-300. PubMed ID: 20123908
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of TAZ-TEAD complex reveals a distinct interaction mode from that of YAP-TEAD complex.
Kaan HYK; Chan SW; Tan SKJ; Guo F; Lim CJ; Hong W; Song H
Sci Rep; 2017 May; 7(1):2035. PubMed ID: 28515457
[TBL] [Abstract][Full Text] [Related]
5. Computational insights into the interaction mechanism of transcription cofactor vestigial-like protein 4 binding to TEA domain transcription factor 4 by molecular dynamics simulation and molecular mechanics generalized Born/surface area) calculation.
Gao J; Zhang Y; Chen H; Chen Q; Feng D; Zhang L; Li C
J Biomol Struct Dyn; 2019 Jul; 37(10):2538-2545. PubMed ID: 30051771
[TBL] [Abstract][Full Text] [Related]
6. Rational cyclization-based minimization of entropy penalty upon the binding of Nrf2-derived linear peptides to Keap1: A new strategy to improve therapeutic peptide activity against sepsis.
Chen K; Huang L; Shen B
Biophys Chem; 2019 Jan; 244():22-28. PubMed ID: 30465941
[TBL] [Abstract][Full Text] [Related]
7. Structural and ligand-binding analysis of the YAP-binding domain of transcription factor TEAD4.
Li Y; Liu S; Ng EY; Li R; Poulsen A; Hill J; Pobbati AV; Hung AW; Hong W; Keller TH; Kang C
Biochem J; 2018 Jun; 475(12):2043-2055. PubMed ID: 29760238
[TBL] [Abstract][Full Text] [Related]
8. DNA-binding mechanism of the Hippo pathway transcription factor TEAD4.
Shi Z; He F; Chen M; Hua L; Wang W; Jiao S; Zhou Z
Oncogene; 2017 Jul; 36(30):4362-4369. PubMed ID: 28368398
[TBL] [Abstract][Full Text] [Related]
9. Design, cyclization, and optimization of MMP13-TIMP1 interaction-derived self-inhibitory peptides against chondrocyte senescence in osteoarthritis.
Zhang W; Zhang C; Luo C; Zhan Y; Zhong B
Int J Biol Macromol; 2019 Jan; 121():921-929. PubMed ID: 30352228
[TBL] [Abstract][Full Text] [Related]
10. Molecular dynamics simulations study of influence of Tyr422Ala mutation on transcriptional enhancer activation domain 4 (TEAD4) and transcription co-activators complexes.
Niu RJ; Zheng QC; Zhang HX
J Theor Biol; 2019 Jul; 472():27-35. PubMed ID: 30978352
[TBL] [Abstract][Full Text] [Related]
11. OTUD6A orchestrates complex modulation of TEAD4-mediated transcriptional programs.
Kim HJ; Choi Y; Lee Y; Hwangbo M; Kim J
FEBS Lett; 2024 May; 598(9):1045-1060. PubMed ID: 38594215
[TBL] [Abstract][Full Text] [Related]
12. Structure-based derivation and optimization of YAP-like coactivator-derived peptides to selectively target TEAD family transcription factors by hydrocarbon stapling and cyclization.
He B; Wu T; He P; Lv F; Liu H
Chem Biol Drug Des; 2021 Jun; 97(6):1129-1136. PubMed ID: 33283479
[TBL] [Abstract][Full Text] [Related]
13. Targeting Hippo pathway by specific interruption of YAP-TEAD interaction using cyclic YAP-like peptides.
Zhou Z; Hu T; Xu Z; Lin Z; Zhang Z; Feng T; Zhu L; Rong Y; Shen H; Luk JM; Zhang X; Qin N
FASEB J; 2015 Feb; 29(2):724-32. PubMed ID: 25384421
[TBL] [Abstract][Full Text] [Related]
14. Structure-based derivation and intramolecular cyclization of peptide inhibitors from PD-1/PD-L1 complex interface as immune checkpoint blockade for breast cancer immunotherapy.
Zhou K; Lu J; Yin X; Xu H; Li L; Ma B
Biophys Chem; 2019 Oct; 253():106213. PubMed ID: 31276987
[TBL] [Abstract][Full Text] [Related]
15. TEA Domain Transcription Factor 4 Is the Major Mediator of Yes-Associated Protein Oncogenic Activity in Mouse and Human Hepatoblastoma.
Zhang J; Liu P; Tao J; Wang P; Zhang Y; Song X; Che L; Sumazin P; Ribback S; Kiss A; Schaff Z; Cigliano A; Dombrowski F; Cossu C; Pascale RM; Calvisi DF; Monga SP; Chen X
Am J Pathol; 2019 May; 189(5):1077-1090. PubMed ID: 30794805
[TBL] [Abstract][Full Text] [Related]
16. Rational design and chemical modification of TEAD coactivator peptides to target hippo signaling pathway against gastrointestinal cancers.
Gao S; Wang Y; Ji L
J Recept Signal Transduct Res; 2021 Aug; 41(4):408-415. PubMed ID: 32912021
[TBL] [Abstract][Full Text] [Related]
17. Increased TEAD4 expression and nuclear localization in colorectal cancer promote epithelial-mesenchymal transition and metastasis in a YAP-independent manner.
Liu Y; Wang G; Yang Y; Mei Z; Liang Z; Cui A; Wu T; Liu CY; Cui L
Oncogene; 2016 May; 35(21):2789-800. PubMed ID: 26387538
[TBL] [Abstract][Full Text] [Related]
18. The surprising features of the TEAD4-Vgll1 protein-protein interaction.
Mesrouze Y; Hau JC; Erdmann D; Zimmermann C; Fontana P; Schmelzle T; Chène P
Chembiochem; 2014 Mar; 15(4):537-42. PubMed ID: 24504694
[TBL] [Abstract][Full Text] [Related]
19. TEAD4-YAP interaction regulates tumoral growth by controlling cell-cycle arrest at the G1 phase.
Takeuchi S; Kasamatsu A; Yamatoji M; Nakashima D; Endo-Sakamoto Y; Koide N; Takahara T; Shimizu T; Iyoda M; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
Biochem Biophys Res Commun; 2017 Apr; 486(2):385-390. PubMed ID: 28315328
[TBL] [Abstract][Full Text] [Related]
20. Molecular design and rational optimization of synergistic effect between the two wings of a roughly orthogonal cation-π-π stacking system at nasopharyngeal carcinoma YAP1-TEAD4 parallel Helix-Helix interaction interface.
Zhu H; Xu S; Wu J; Hu J; Mao X
J Mol Recognit; 2022 Dec; 35(12):e2986. PubMed ID: 36326001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
